Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Allen Nissenson Insider Profile
4 Followers
Allen Nissenson, CMO at DaVita, holds 124.20K shares in Rockwell Med (Ticker: RMTI), holds 9.38K shares in Elicio Therapeutics (Ticker: ELTX), holds 11.54K shares in DaVita (Ticker: DVA).
Allen Nissenson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Allen Nissenson holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 23, 2022 - May 23, 2023
Return:-32.30%
The most profitable trade made by Allen Nissenson
Allen Nissenson's Trading History
DaVita
Feb 18, 2014
CMO
Uninformative Sell
473.12K
$1.45M
Rockwell Med
May 25, 2023
Director
Uninformative Buy
―
$183.82K
Elicio Therapeutics
May 23, 2022
Director
Informative Buy
10.93K
$77.22K
List of latest transactions for each holding click on a transaction to see Allen Nissenson's performance on stock
You May Also Like
Allen Nissenson insider profile FAQ
What is the percentage of profitable transactions made by Allen Nissenson?
The percentage of profitable transactions made by Allen Nissenson is ―.
What is the average return per transaction made by Allen Nissenson?
The average return per transaction made by Allen Nissenson is ―.
What stocks does Allen Nissenson hold?
Allen Nissenson holds: DVA, RMTI, ELTX stocks.
What was Allen Nissenson’s latest transaction?
Allen Nissenson latest transaction was an Uninformative Buy of ―.
What was Allen Nissenson's most profitable transaction?
Allen Nissenson’s most profitable transaction was an Informative Buy of ELTX stock on May 23, 2022. The return on the trade was -32.30%.
What is Allen Nissenson's role in DaVita?
Allen Nissenson's role in DaVita is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.